成功根除幽门螺杆菌后再感染率和内镜变化。
Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori.
机构信息
Center for Cancer Prevention and Detection, National Cancer Center, Madu1-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, 410-769, South Korea.
出版信息
World J Gastroenterol. 2010 Jan 14;16(2):251-5. doi: 10.3748/wjg.v16.i2.251.
Abstract
AIM
To determine the long-term outcomes regarding reinfection with Helicobacter pylori (H. pylori) and endoscopic changes after successful H. pylori eradication.
METHODS
From June 1994 to January 2007, 186 patients (M:F = 98:88; mean age 50.0 +/- 11.4 years), in whom H. pylori had been successfully eradicated, were enrolled. The mean duration of follow up was 41.2 +/- 24.0 mo.
RESULTS
H. pylori reinfection occurred in 58 patients (31.2%). The average annual reinfection rate was 9.1% per patient year. No recurrence of peptic ulcer was detected at the follow up endoscopy. There were no significant differences between the H. pylori eradication regimens for the reinfection rate and no significant differences in endoscopic findings between the H. pylori-recurred group and the H. pylori-cured group.
CONCLUSION
The reinfection rate in Korea is 9.1% which represents a decreasing trend. There was no relationship between H. pylori infection status and changes in endoscopic findings. There was also no recurrence or aggravation of ulcers.
摘要
目的
确定成功根除幽门螺杆菌（H. pylori）后再感染和内镜变化的长期结果。
方法
1994 年 6 月至 2007 年 1 月，共纳入 186 例（男：女=98：88；平均年龄 50.0+/-11.4 岁）成功根除 H. pylori 的患者。平均随访时间为 41.2+/-24.0 个月。
结果
58 例（31.2%）患者发生 H. pylori 再感染。每位患者每年的再感染率平均为 9.1%。随访内镜检查未发现消化性溃疡复发。不同的 H. pylori 根除方案之间的再感染率无显著差异，H. pylori 再感染组和 H. pylori 治愈组之间的内镜表现也无显著差异。
结论
韩国的再感染率为 9.1%，呈下降趋势。H. pylori 感染状况与内镜表现变化之间无关系。也没有溃疡的复发或加重。
相似文献
1
Reinfection rate and endoscopic changes after successful eradication of Helicobacter pylori.成功根除幽门螺杆菌后再感染率和内镜变化。
World J Gastroenterol. 2010 Jan 14;16(2):251-5. doi: 10.3748/wjg.v16.i2.251.
2
Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.韩国幽门螺杆菌再感染的根除率：一项回顾性研究。
J Gastroenterol Hepatol. 2019 Oct;34(10):1696-1702. doi: 10.1111/jgh.14639. Epub 2019 Mar 14.
3
[Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication].[幽门螺杆菌感染一线和二线治疗的根除率以及成功根除后的再感染率]
Korean J Gastroenterol. 2007 Sep;50(3):170-5.
4
Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan.日本幽门螺杆菌感染复发及消化性溃疡成功根除后的长期结局
J Clin Gastroenterol. 2002 Feb;34(2):129-34. doi: 10.1097/00004836-200202000-00005.
5
Helicobacter pylori reinfection rate and duodenal ulcer recurrence in Korea.韩国幽门螺杆菌再感染率与十二指肠溃疡复发情况
J Clin Gastroenterol. 1998 Dec;27(4):321-6. doi: 10.1097/00004836-199812000-00008.
6
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.幽门螺杆菌再感染在接受抗菌治疗治愈的消化性溃疡患者中很少见。
Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1161-3. doi: 10.1097/00042737-199612000-00005.
7
Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea.韩国的幽门螺杆菌再感染率及其相关因素的长期随访研究。
Helicobacter. 2013 Apr;18(2):135-42. doi: 10.1111/hel.12018. Epub 2012 Oct 8.
8
Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection.韩国一线和二线根除治疗后幽门螺杆菌复发：复发或再感染问题
Helicobacter. 2014 Jun;19(3):202-6. doi: 10.1111/hel.12117. Epub 2014 Mar 11.
9
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).发展中国家（摩洛哥）成功根除后幽门螺杆菌的流行及其复发情况。
Clin Res Hepatol Gastroenterol. 2013 Nov;37(5):519-26. doi: 10.1016/j.clinre.2013.02.003. Epub 2013 Apr 6.
10
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.东南亚患者幽门螺杆菌成功根除后的再感染与十二指肠溃疡复发：两年随访结果
Eur J Gastroenterol Hepatol. 1996 Dec;8(12):1157-60. doi: 10.1097/00042737-199612000-00004.
引用本文的文献
1
[The Recurrence of Infection: Recrudescence Versus Reinfection].[感染的复发：再燃与再感染]
Korean J Helicobacter Up Gastrointest Res. 2023 Dec;23(4):317-320. doi: 10.7704/kjhugr.2023.0059. Epub 2023 Dec 8.
2
Chinese Consensus Report on Family-Based Infection Control and Management (2021 Edition).中国家族性感染防控与管理专家共识（2021 年版）
Gut. 2022 Feb;71(2):238-253. doi: 10.1136/gutjnl-2021-325630. Epub 2021 Nov 26.
3
Helicobacter pylori recrudescence and its influencing factors.幽门螺杆菌再感染及其影响因素。
J Cell Mol Med. 2019 Dec;23(12):7919-7925. doi: 10.1111/jcmm.14682. Epub 2019 Sep 19.
4
Inference from the analysis of genetic structure of Helicobacter pylori strains isolates from two paediatric patients with recurrent infection.从两名复发性感染的儿科患者分离的幽门螺杆菌菌株遗传结构分析中推断。
BMC Microbiol. 2019 Aug 8;19(1):184. doi: 10.1186/s12866-019-1554-z.
5
Rate and predictive factors of recurrence: Analysis of a screening cohort.复发率及预测因素：一项筛查队列分析
Saudi J Gastroenterol. 2019 Jul-Aug;25(4):251-256. doi: 10.4103/sjg.SJG_456_18.
6
Helicobacter pylori, transmission routes and recurrence of infection: state of the art.幽门螺杆菌、传播途径与感染复发：最新进展
Acta Biomed. 2018 Dec 17;89(8-S):72-76. doi: 10.23750/abm.v89i8-S.7947.
7
High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients.立陶宛消化性溃疡患者幽门螺杆菌再感染率高。
World J Gastrointest Pathophysiol. 2016 Feb 15;7(1):181-5. doi: 10.4291/wjgp.v7.i1.181.
8
Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates.二十多年来儿童幽门螺杆菌感染的随访（1988-2007 年）：持续感染率、复发率和获得率。
Epidemiol Infect. 2014 Apr;142(4):767-75. doi: 10.1017/S0950268813001428. Epub 2013 Jun 28.
9
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701).六拉丁美洲国家（SWOG 试验 S0701）中幽门螺杆菌感染的流行病学。
Cancer Causes Control. 2013 Feb;24(2):209-15. doi: 10.1007/s10552-012-0117-5. Epub 2012 Dec 12.
10
Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.幽门螺杆菌中性粒细胞激活蛋白作为治疗幽门螺杆菌炎症新药的靶标。
World J Gastroenterol. 2011 Jun 7;17(21):2585-91. doi: 10.3748/wjg.v17.i21.2585.
本文引用的文献
1
Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication.发达国家和发展中国家幽门螺杆菌的复发情况：根除治疗后¹³C尿素呼气试验随访的荟萃分析
Helicobacter. 2008 Feb;13(1):56-61. doi: 10.1111/j.1523-5378.2008.00571.x.
2
[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years].[幽门螺杆菌感染一线三联疗法根除率的趋势：近八年单中心经验]
Korean J Gastroenterol. 2006 Sep;48(3):156-61.
3
Gastric atrophy, diagnosing and staging.胃萎缩的诊断与分期
World J Gastroenterol. 2006 Sep 28;12(36):5757-62. doi: 10.3748/wjg.v12.i36.5757.
4
Long-term study of re-infection following successful eradication of Helicobacter pylori infection.幽门螺杆菌感染成功根除后再感染的长期研究。
Aliment Pharmacol Ther. 2006 May 1;23(9):1355-8. doi: 10.1111/j.1365-2036.2006.02899.x.
5
Reinfection after successful eradication of Helicobacter pylori: a 2-year prospective study in Alaska Natives.幽门螺杆菌成功根除后的再感染：阿拉斯加原住民的一项为期2年的前瞻性研究。
Aliment Pharmacol Ther. 2006 Apr 15;23(8):1215-23. doi: 10.1111/j.1365-2036.2006.02880.x.
6
Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.韩国采用含铋剂的二线四联疗法根除幽门螺杆菌后的长期结局
Eur J Gastroenterol Hepatol. 2006 May;18(5):515-9. doi: 10.1097/00042737-200605000-00010.
7
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.幽门螺杆菌根除对老年人反流性食管炎和慢性胃炎结局的影响。一项随机、多中心、为期八个月的研究。
Gerontology. 2006;52(2):99-106. doi: 10.1159/000090955.
8
Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.幽门螺杆菌根除对萎缩性胃炎和肠化生的影响：一项3年随访研究
World J Gastroenterol. 2005 Nov 7;11(41):6518-20. doi: 10.3748/wjg.v11.i41.6518.
9
The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.幽门螺杆菌感染的复发：发生率及影响因素。一项批判性综述。
Am J Gastroenterol. 2005 Sep;100(9):2083-99. doi: 10.1111/j.1572-0241.2005.50043.x.
10
Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.越南幽门螺杆菌根除治疗的长期随访：再感染与临床结局
Aliment Pharmacol Ther. 2005 Apr 15;21(8):1047-53. doi: 10.1111/j.1365-2036.2005.02408.x.
Zotero 插件